Time Pharmaceuticals Limited has scheduled its 30th Annual General Meeting (AGM) on 12th Ashwin, 2081. The meeting will take place at Soaltee Westend Resort, Chitwan, starting at 10 AM.
Key Agendas for the AGM:
- Approval of the company’s annual report for the fiscal year.
- Approval of the auditor’s report for the fiscal year 2080/81, including the profit and loss statements, financial reports, and cash flow statements.
- Appointment of auditors and determination of their remuneration for the fiscal year 2081/82.
- Reformation of the Board of Directors.
- Issuance of an Initial Public Offering (IPO) to the general public.
- Selection of the Share Issue Manager for the upcoming IPO.
- Passing a resolution for amendments to the company’s rules and regulations.
- Authorizing the Board of Directors to modify the Articles of Association and regulations for the issuance of primary shares as directed by the regulatory body.
Ratings and Background
ICRA Nepal has reaffirmed the company’s long-term credit rating of [ICRANP] LBBB- (L triple B minus) and the short-term rating of [ICRANP] A3 (A three) for Time Pharmaceuticals Limited’s obligations.
About Time Pharmaceuticals
Founded in 1994 and operational since 1997, Time Pharmaceuticals is a prominent pharmaceutical company in Nepal. The company specializes in reverse engineering pharmaceutical molecules and produces a wide range of therapeutic drugs, including antibiotics.
